Lake Street Maintains Buy on TELA Bio, Lowers Price Target to $2
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Frank Takkinen maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $3 to $2.
Lake Street analyst Frank Takkinen maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $3 to $2.